![]() |
|
|
Vol. 287, Issue 1, 395-402, October 1998
TNO Nutrition and Food Research Institute, Toxicology Division,
Zeist, Netherlands
Palmitoyl carnitine chloride (PCC) has been shown to be an effective
enhancer of intestinal transport of hydrophilic molecules. The exact
mechanism by which the epithelial barrier function is decreased is not
clear. In an attempt to elucidate the mechanism of action of PCC, we
studied the relationship among absorption enhancement, cell viability
and tight junction protein localization in the human colonic Caco-2
cell line and the rat small intestinal cell line IEC-18. Filter-grown
cells were exposed to 0 to 1 mM PCC for 30 min, and the efficacy of PCC
treatment was determined by assessing the transepithelial electrical
resistance and the apparent permeability for mannitol and PEG-4000.
Membrane lysis and cytotoxicity were assessed by measurement of lactate
dehydrogenase leakage and uptake of propidium iodide and neutral red.
The immunolocalization of the tight junctional protein ZO-1 was
quantified using CSLM and image-processing software. In both cell
lines, PCC caused a dose-dependent decrease in transepithelial
electrical resistance and a concomitant increase in the permeability
for mannitol and PEG-4000. The transport enhancement was accompanied by
an increase in apical membrane permeability and a reduction in cell
viability. At higher PCC concentrations (
0.4 mM), the distribution of
the tight junctional protein ZO-1 was changed and cells were unable to
recover viability. PCC is effective as an absorption enhancer for
hydrophilic macromolecules. However, lytic effects on the cell membrane
and reduced cell viability were concomitant with transport enhancement.
This article has been cited by other articles:
![]() |
N. N. Salama, A. Fasano, M. Thakar, and N. D. Eddington The Impact of {Delta}G on the Oral Bioavailability of Low Bioavailable Therapeutic Agents J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Patel, A. P. Economides, and N. G. Byrne Effects of Palmitoyl Carnitine on Perfused Heart and Papillary Muscle Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(2): 85 - 96. [Abstract] [PDF] |
||||